ADAM32
gene geneOn this page
Summary
ADAM32 (ADAM metallopeptidase domain 32, HGNC:15479) is a protein-coding gene on chromosome 8p11.22, encoding Disintegrin and metalloproteinase domain-containing protein 32 (Q8TC27). May play a role in sperm development and fertilization This is a non-catalytic metalloprotease-like protein.
This gene encodes a member of the disintegrin family of membrane-anchored proteins that play a role in diverse biological processes such as brain development, fertilization, tumor development and inflammation. This gene is predominantly expressed in the testis. The encoded protein undergoes proteolytic processing to generate a mature polypeptide comprised of an metalloprotease, disintegrin and epidermal growth factor-like domains. This gene is located in a cluster of other disintegrin and metallopeptidase family genes on chromosome 8. Alternative splicing results in multiple transcript variants encoding different isoforms.
Source: NCBI Gene 203102 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 142 total — 1 pathogenic
- MANE Select transcript:
NM_145004
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15479 |
| Approved symbol | ADAM32 |
| Name | ADAM metallopeptidase domain 32 |
| Location | 8p11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000197140 |
| Ensembl biotype | protein_coding |
| OMIM | 618602 |
| Entrez | 203102 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 12 protein_coding, 3 retained_intron, 1 protein_coding_CDS_not_defined
ENST00000379907, ENST00000399831, ENST00000437682, ENST00000517416, ENST00000518259, ENST00000519315, ENST00000520691, ENST00000521741, ENST00000522506, ENST00000523400, ENST00000524303, ENST00000864644, ENST00000864645, ENST00000864646, ENST00000953391, ENST00000953392
RefSeq mRNA: 2 — MANE Select: NM_145004
NM_001313994, NM_145004
CCDS: CCDS47846, CCDS83286
Canonical transcript exons
ENST00000379907 — 25 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001644801 | 39233899 | 39234082 |
| ENSE00001718374 | 39186909 | 39187045 |
| ENSE00001740627 | 39281136 | 39281174 |
| ENSE00001764341 | 39232027 | 39232135 |
| ENSE00001768819 | 39169916 | 39169997 |
| ENSE00001800049 | 39211144 | 39211324 |
| ENSE00002129166 | 39107734 | 39107833 |
| ENSE00002709940 | 39165030 | 39165196 |
| ENSE00003462199 | 39223040 | 39223238 |
| ENSE00003470638 | 39270876 | 39270914 |
| ENSE00003498621 | 39164764 | 39164835 |
| ENSE00003499791 | 39283586 | 39283624 |
| ENSE00003512359 | 39118086 | 39118165 |
| ENSE00003563245 | 39257187 | 39257343 |
| ENSE00003566150 | 39151377 | 39151548 |
| ENSE00003598611 | 39254414 | 39254516 |
| ENSE00003603280 | 39274312 | 39274350 |
| ENSE00003605948 | 39136657 | 39136718 |
| ENSE00003632102 | 39275828 | 39275866 |
| ENSE00003651540 | 39221610 | 39221702 |
| ENSE00003671566 | 39147130 | 39147205 |
| ENSE00003681295 | 39149791 | 39149867 |
| ENSE00003682952 | 39246083 | 39246166 |
| ENSE00003683769 | 39160897 | 39160965 |
| ENSE00003847739 | 39284793 | 39284917 |
Expression profiles
Bgee: expression breadth ubiquitous, 131 present calls, max score 90.40.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0968 / max 73.9779, expressed in 8 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 88583 | 0.0884 | 6 |
| 205160 | 0.0084 | 4 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 90.40 | gold quality |
| right testis | UBERON:0004534 | 89.80 | gold quality |
| testis | UBERON:0000473 | 89.44 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.80 | gold quality |
| corpus callosum | UBERON:0002336 | 80.04 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.31 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.35 | gold quality |
| endometrium | UBERON:0001295 | 73.36 | gold quality |
| body of pancreas | UBERON:0001150 | 71.68 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 71.39 | gold quality |
| sural nerve | UBERON:0015488 | 70.88 | gold quality |
| adrenal tissue | UBERON:0018303 | 70.78 | gold quality |
| colonic epithelium | UBERON:0000397 | 69.81 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 69.62 | gold quality |
| primary visual cortex | UBERON:0002436 | 68.74 | gold quality |
| ascending aorta | UBERON:0001496 | 68.46 | gold quality |
| thoracic aorta | UBERON:0001515 | 68.37 | gold quality |
| ventricular zone | UBERON:0003053 | 67.86 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 67.64 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 67.53 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 67.53 | gold quality |
| left adrenal gland | UBERON:0001234 | 67.16 | gold quality |
| adrenal gland | UBERON:0002369 | 67.16 | gold quality |
| pancreas | UBERON:0001264 | 66.93 | gold quality |
| rectum | UBERON:0001052 | 66.73 | gold quality |
| hypothalamus | UBERON:0001898 | 66.42 | gold quality |
| tibial artery | UBERON:0007610 | 66.41 | gold quality |
| popliteal artery | UBERON:0002250 | 66.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 66.33 | gold quality |
| mucosa of stomach | UBERON:0001199 | 66.30 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | no | 281.20 |
| E-GEOD-124858 | no | 164.56 |
| E-MTAB-7381 | no | 145.59 |
| E-ANND-3 | no | 2.04 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
6 targeting ADAM32, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-6125 | 95.17 | 67.26 | 91 |
| HSA-MIR-6808-3P | 94.13 | 65.24 | 516 |
Cross-species orthologs
9 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | adam10b | ENSDARG00000015502 |
| danio_rerio | adam10a | ENSDARG00000053468 |
| danio_rerio | adam9b | ENSDARG00000057138 |
| mus_musculus | Adam32 | ENSMUSG00000037437 |
| rattus_norvegicus | Adam32 | ENSRNOG00000025728 |
| drosophila_melanogaster | mmd | FBGN0259110 |
| drosophila_melanogaster | kuz | FBGN0259984 |
| caenorhabditis_elegans | sup-17 | WBGENE00006324 |
| caenorhabditis_elegans | WBGENE00006804 |
Paralogs (20): ADAM22 (ENSG00000008277), ADAM28 (ENSG00000042980), ADAM7 (ENSG00000069206), ADAM11 (ENSG00000073670), ADAM2 (ENSG00000104755), ADAM23 (ENSG00000114948), ADAM20 (ENSG00000134007), ADAMDEC1 (ENSG00000134028), ADAM30 (ENSG00000134249), ADAM19 (ENSG00000135074), ADAM10 (ENSG00000137845), ADAM21 (ENSG00000139985), ADAM15 (ENSG00000143537), ADAM12 (ENSG00000148848), ADAM33 (ENSG00000149451), ADAM8 (ENSG00000151651), ADAM17 (ENSG00000151694), ADAM29 (ENSG00000168594), ADAM9 (ENSG00000168615), ADAM18 (ENSG00000168619)
Protein
Protein identifiers
Disintegrin and metalloproteinase domain-containing protein 32 — Q8TC27 (reviewed: Q8TC27)
All UniProt accessions (7): E3W988, E5RGK7, E5RJE6, E5RJY7, E7EPX8, E7ER82, Q8TC27
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in sperm development and fertilization This is a non-catalytic metalloprotease-like protein.
Subcellular location. Membrane.
Tissue specificity. Testis specific.
RefSeq proteins (2): NP_001300923, NP_659441* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000742 | EGF | Domain |
| IPR001590 | Peptidase_M12B | Domain |
| IPR001762 | Disintegrin_dom | Domain |
| IPR002870 | Peptidase_M12B_N | Domain |
| IPR006586 | ADAM_Cys-rich | Domain |
| IPR018358 | Disintegrin_CS | Conserved_site |
| IPR024079 | MetalloPept_cat_dom_sf | Homologous_superfamily |
| IPR034027 | Reprolysin_adamalysin | Domain |
| IPR036436 | Disintegrin_dom_sf | Homologous_superfamily |
Pfam: PF00200, PF01421, PF01562, PF08516, PF23106
UniProt features (30 total): disulfide bond 7, sequence variant 6, glycosylation site 4, domain 3, compositionally biased region 2, topological domain 2, signal peptide 1, propeptide 1, modified residue 1, chain 1, transmembrane region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TC27-F1 | 76.71 | 0.44 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 17
Disulfide bonds (7): 295–378, 337–362, 339–344, 450–471, 626–636, 630–642, 644–653
Glycosylation sites (4): 39, 125, 465, 598
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 57 (showing top):
GOBP_SINGLE_FERTILIZATION, GOMF_METALLOPEPTIDASE_ACTIVITY, GOCC_CELL_SURFACE, GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT, GOBP_SPERM_EGG_RECOGNITION, GOBP_SEX_DIFFERENTIATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_FERTILIZATION, GOBP_CELL_CELL_RECOGNITION, GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA, GOBP_MALE_SEX_DIFFERENTIATION, GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS, GOCC_MOTILE_CILIUM, GOCC_SPERM_PRINCIPAL_PIECE, GOBP_PROTEOLYSIS
GO Biological Process (4): proteolysis (GO:0006508), cell adhesion (GO:0007155), binding of sperm to zona pellucida (GO:0007339), male gonad development (GO:0008584)
GO Molecular Function (3): metalloendopeptidase activity (GO:0004222), protein binding (GO:0005515), metallopeptidase activity (GO:0008237)
GO Cellular Component (3): plasma membrane (GO:0005886), cell surface (GO:0009986), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| protein metabolic process | 1 |
| cellular process | 1 |
| sperm-egg recognition | 1 |
| gonad development | 1 |
| development of primary male sexual characteristics | 1 |
| endopeptidase activity | 1 |
| metallopeptidase activity | 1 |
| binding | 1 |
| peptidase activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
662 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ADAM32 | IZUMO2 | Q6UXV1 | 560 |
| ADAM32 | IZUMO4 | Q1ZYL8 | 535 |
| ADAM32 | PLEKHA2 | Q9HB19 | 516 |
| ADAM32 | TEKTIP1 | A6NCJ1 | 465 |
| ADAM32 | ZPBP2 | Q6X784 | 457 |
| ADAM32 | TSACC | Q96A04 | 448 |
| ADAM32 | PLPP5 | Q8NEB5 | 447 |
| ADAM32 | TEX55 | Q96M34 | 442 |
| ADAM32 | C22orf23 | Q9BZE7 | 434 |
| ADAM32 | IZUMO3 | Q5VZ72 | 418 |
| ADAM32 | CATSPERT | Q53TS8 | 399 |
| ADAM32 | ZAN | Q9Y493 | 395 |
| ADAM32 | HTRA4 | P83105 | 388 |
| ADAM32 | CCDC54 | Q8NEL0 | 387 |
| ADAM32 | DDHD2 | O94830 | 382 |
IntAct
9 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CLDN8 | ADAM32 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ADAM32 | NUFIP2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ADAM32 | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| CDH23 | SGTA | psi-mi:“MI:0914”(association) | 0.350 |
| TACC3 | TNC | psi-mi:“MI:0914”(association) | 0.350 |
| CLDN8 | ADAM32 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (41): ITGA5 (Affinity Capture-MS), STAT5B (Affinity Capture-MS), ASPHD2 (Affinity Capture-MS), LCLAT1 (Affinity Capture-MS), NOTCH3 (Affinity Capture-MS), JAG2 (Affinity Capture-MS), PLXNA2 (Affinity Capture-MS), KIAA0391 (Affinity Capture-MS), ADAMTS1 (Affinity Capture-MS), ADAM9 (Affinity Capture-MS), INTS4 (Affinity Capture-MS), KTN1 (Affinity Capture-MS), GAS6 (Affinity Capture-MS), IQCB1 (Affinity Capture-MS), BCL2L11 (Affinity Capture-MS)
ESM2 similar proteins: A0A292G9J6, A0A8M9PFP2, A1L2K1, A2A863, A7E2Z9, B0S5G3, B5MFE9, F1R520, F7A4A7, F8VQ03, O93449, O94985, P16144, P35447, P53813, P98089, Q08761, Q0V9V5, Q0VCN6, Q28483, Q3ZCN5, Q5R9Q9, Q5RCW9, Q5RD64, Q61592, Q63772, Q64632, Q6DDW2, Q6DFV8, Q6PZE0, Q6Q0N0, Q8BH34, Q8BJD1, Q8CFM6, Q8CIZ8, Q8CJ69, Q8K410, Q8N2E2, Q8N8U9, Q8R553
Diamond homologs: A2CJE4, C5FUK3, D4B1G0, D4DCV9, F8VQ03, O15072, O43184, O77780, O93517, O93518, P0C6R9, P0DJ87, P0DM89, P17497, P31989, P70505, P97776, Q05910, Q0NZX6, Q0NZX7, Q0NZX8, Q0NZY0, Q13443, Q28478, Q28483, Q28660, Q3TTE0, Q4JCS0, Q4JCS1, Q5BK84, Q60411, Q60472, Q60718, Q60813, Q61072, Q61824, Q63202, Q6NVV9, Q801Z4, Q8JIY1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
142 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 100 |
| Likely benign | 17 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 150494 | GRCh38/hg38 8p11.23-11.22(chr8:38046362-39172253)x1 | Pathogenic |
SpliceAI
4179 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 8:39118162:ATAT:A | donor_gain | 1.0000 |
| 8:39118166:G:GG | donor_gain | 1.0000 |
| 8:39147123:T:G | acceptor_gain | 1.0000 |
| 8:39147126:TCAG:T | acceptor_loss | 1.0000 |
| 8:39147128:A:T | acceptor_loss | 1.0000 |
| 8:39147129:GAT:G | acceptor_gain | 1.0000 |
| 8:39147129:GATA:G | acceptor_gain | 1.0000 |
| 8:39147129:GATAT:G | acceptor_gain | 1.0000 |
| 8:39147201:TTCAG:T | donor_loss | 1.0000 |
| 8:39147202:TCAG:T | donor_loss | 1.0000 |
| 8:39147203:CAG:C | donor_loss | 1.0000 |
| 8:39147204:AG:A | donor_loss | 1.0000 |
| 8:39147205:GG:G | donor_loss | 1.0000 |
| 8:39147206:GTA:G | donor_loss | 1.0000 |
| 8:39147207:T:A | donor_loss | 1.0000 |
| 8:39149861:GAC:G | donor_gain | 1.0000 |
| 8:39151542:TGAAA:T | donor_gain | 1.0000 |
| 8:39151549:G:GG | donor_gain | 1.0000 |
| 8:39160895:A:AG | acceptor_gain | 1.0000 |
| 8:39160896:G:GG | acceptor_gain | 1.0000 |
| 8:39164762:A:AG | acceptor_gain | 1.0000 |
| 8:39164762:AGTAT:A | acceptor_gain | 1.0000 |
| 8:39164763:G:GG | acceptor_gain | 1.0000 |
| 8:39164763:GTAT:G | acceptor_gain | 1.0000 |
| 8:39164763:GTATG:G | acceptor_gain | 1.0000 |
| 8:39164836:G:GG | donor_gain | 1.0000 |
| 8:39186907:A:AG | acceptor_gain | 1.0000 |
| 8:39186908:G:GA | acceptor_gain | 1.0000 |
| 8:39187041:GTTGT:G | donor_gain | 1.0000 |
| 8:39187046:G:GG | donor_gain | 1.0000 |
AlphaMissense
5194 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 8:39223217:T:A | C502S | 1.000 |
| 8:39223218:G:C | C502S | 1.000 |
| 8:39211304:T:A | C405S | 0.999 |
| 8:39211305:G:C | C405S | 0.999 |
| 8:39223085:T:A | C458S | 0.999 |
| 8:39223086:G:C | C458S | 0.999 |
| 8:39223124:T:A | C471S | 0.999 |
| 8:39223125:G:C | C471S | 0.999 |
| 8:39223181:T:A | C490S | 0.999 |
| 8:39223182:G:C | C490S | 0.999 |
| 8:39223217:T:C | C502R | 0.999 |
| 8:39223218:G:A | C502Y | 0.999 |
| 8:39223218:G:T | C502F | 0.999 |
| 8:39223219:T:G | C502W | 0.999 |
| 8:39232133:G:C | W544C | 0.999 |
| 8:39232133:G:T | W544C | 0.999 |
| 8:39233910:G:A | C549Y | 0.999 |
| 8:39233924:T:A | C554S | 0.999 |
| 8:39233924:T:C | C554R | 0.999 |
| 8:39233925:G:A | C554Y | 0.999 |
| 8:39233925:G:C | C554S | 0.999 |
| 8:39233926:T:G | C554W | 0.999 |
| 8:39233999:T:A | C579S | 0.999 |
| 8:39233999:T:C | C579R | 0.999 |
| 8:39234000:G:A | C579Y | 0.999 |
| 8:39234000:G:C | C579S | 0.999 |
| 8:39234001:C:G | C579W | 0.999 |
| 8:39234068:T:A | C602S | 0.999 |
| 8:39234068:T:C | C602R | 0.999 |
| 8:39234069:G:A | C602Y | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000004010 (8:39195184 C>T), RS1000035586 (8:39279528 C>T), RS1000050758 (8:39238754 A>G), RS1000053634 (8:39187587 T>C), RS1000062824 (8:39244980 T>C), RS1000073021 (8:39262871 AT>A,ATT), RS1000089788 (8:39180332 G>A,T), RS1000107572 (8:39266594 C>A,T), RS1000125567 (8:39200010 C>A), RS1000157532 (8:39139685 A>G,T), RS1000177539 (8:39189537 C>T), RS1000178780 (8:39143962 G>T), RS1000203106 (8:39232901 A>G), RS1000215476 (8:39148785 T>G), RS1000226672 (8:39276385 G>A,T)
Disease associations
OMIM: gene MIM:618602 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90006920_3 | Herpes simplex virus 2 mgG-1 antibody levels | 4.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009350 | Anti-herpes simplex virus 2 IgG measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: enzyme — M12: Astacin/Adamalysin
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| tobacco tar | decreases expression, decreases reaction | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| diallyl disulfide | decreases expression, decreases reaction | 1 |
| nickel sulfate | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, increases expression | 1 |
| Malathion | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Vanadates | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.